Nantes University Hospital
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1503-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.chu-nantes.fr
Characterization and Support for Neurodevelopmental Disorders Associated with Congenital Heart Defects
Not Applicable
Recruiting
- Conditions
- Neurodevelopmental DisorderCongenital Heart Defects
- Interventions
- Other: Blood samplingDiagnostic Test: Assessment of neurodevelopment (Nantes)Diagnostic Test: Assessment of neurodevelopment (CA)Other: Assessment of the parental stress
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 1206
- Registration Number
- NCT06442592
- Locations
- 🇫🇷
Chu Brest, Brest, Bretagne, France
🇫🇷CHU Nantes, Nantes, Loire-Atlantique, France
🇫🇷CHU Rennes, Rennes, Bretagne, France
Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy
Not yet recruiting
- Conditions
- Acute Myeloid LeukemiaMyelodysplastic SyndromesChronic Myelomonocytic Leukemia
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT06439199
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, Loire-Atlantique, France
Interprofessional Collaborative Practice in Primary Care: Potentially Avoidable Hospitalization
Not yet recruiting
- Conditions
- AgedPrimary Health CareHospitalization
- Interventions
- Other: Primary care team
- First Posted Date
- 2024-05-17
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 500000
- Registration Number
- NCT06420128
- Locations
- 🇫🇷
University Hospital, Nantes, France
Evaluation of a Range of Dermo-cosmetic Products to Treat Skin and Nail Toxicity Linked to Bispecific Anti-GPRC5D Bispecific Antibodies in Multiple Myeloma Patients". Myeloma". Descriptive Pilot Study
Not Applicable
Not yet recruiting
- Conditions
- Myeloma Multiple
- Interventions
- Other: dermo-cosmetic product
- First Posted Date
- 2024-05-17
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06418750
Early and Objective Assessment of Neurological Prognosis in Cardiac Arrest Patients
Recruiting
- Conditions
- Neurologic SymptomsCardiac ArrestIntensive Care Neurological Disorder
- First Posted Date
- 2024-04-26
- Last Posted Date
- 2025-02-26
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 608
- Registration Number
- NCT06387225
- Locations
- 🇫🇷
CHU Nantes, Nantes, France
🇫🇷APHP - Hôpital Cochin, Paris, France
🇫🇷CH Saint-Nazaire, Saint-Nazaire, France
EndoxOmics : Exposome, Endometriosis and Fertility
Completed
- Conditions
- EndometriosisInfertility, Female
- First Posted Date
- 2024-04-10
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 87
- Registration Number
- NCT06356753
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, Loire-Atlantique, France
Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia.
Phase 1
Recruiting
- Conditions
- Acute Leukemia
- Interventions
- Drug: Experimental drug [177Lu]Lu-PentixaTher
- First Posted Date
- 2024-04-10
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 21
- Registration Number
- NCT06356922
- Locations
- 🇫🇷
CHU de Bordeaux, Bordeaux, Gironde, France
🇫🇷CHU de Nantes, Nantes, Loire-Atlantique, France
🇫🇷CHU d'Angers, Angers, Maine et Loire, France
Minimal Residual Disease-based Strategy with T-Cell Redirector After Treatment with Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) in Newly Diagnosed Multiple Myeloma
Phase 2
Recruiting
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2024-04-08
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 103
- Registration Number
- NCT06353022
- Locations
- 🇫🇷
CHU Poitiers, Poitiers, France
🇫🇷CH de la Côte Basque, Bayonne, France
🇫🇷CHU Caen, Caen, France
Clot Formation and Coagulation Factors Consumption in the Clearing Fluid After Arterial Catheter Blood Sampling.
Recruiting
- Conditions
- Intensive Care UnitsArterial Lines
- First Posted Date
- 2024-04-05
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 211
- Registration Number
- NCT06349551
- Locations
- 🇫🇷
Nantes university hospital, Nantes, Loire-atlantique, France
🇫🇷Hospital center, Saint-Nazaire, France
Research Project on the Risk of Discomfort, Pain, Alteration of Skin Condition in Bedpan Use by Patients and Caregivers
Recruiting
- Conditions
- Nurse-Patient Relations
- Interventions
- Other: Questioning the patient during hygiene care
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Nantes University Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT06332495
- Locations
- 🇫🇷
Nantes University Hospital, Nantes, Loire Atlantique, France
🇫🇷CHU Cholet, Cholet, France
🇫🇷CHU Laval, Laval, France
© Copyright 2025. All Rights Reserved by MedPath